Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Date:2/21/2013

2931 and LX7101 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.Lexicon Pharmaceuticals, Inc.
Selected Financial Data

 Consolidated Statements of Operations DataThree Months EndedDecember 31,Year EndedDecember 31,(In thousands, except per share data)2012201120122011(unaudited)  (unaudited)Revenues:Collaborative research

$
218$
320$
783$
,632Subscription and license fees

-23306217Total revenues

2183431,0891,849Operating expenses:Research and development, including stock-based compensation

of $798, $769, $3,673 and $3,249, respectively

20,99028,10782,57491,828Increase (decrease) in fair value of Symphony Icon, Inc
purchase liability

(200)1,5689,8876,766General and administrative, including stock-based compensation

of $792, $584, $2,822 and $2,458, respectively

3,9204,01017,04317,350Total operating expenses

24,71033,685109,504115,944Loss from operations

(24,492)(33,342)(108,415)(114,095)Interest income

5540213255I
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lexicon To Present At The BIO CEO & Investor Conference
2. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
3. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
4. Lexicon to Provide Third Quarter 2012 Financial Results
5. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
6. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
7. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
8. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
9. Lexicon to Provide Second Quarter 2012 Financial Results
10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
11. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... Colo. , July 29, 2014  Encision Inc. ... that prevents dangerous stray electrosurgical burns in minimally invasive ... first quarter ended June 30, 2014. The ... a quarterly net loss of $202 thousand, or $(0.02) ... $2.682 million for a net loss of $311 thousand, ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
Breaking Medicine Technology:Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Calif., Sept. 13, 2011 Edison Pharmaceuticals, Inc. announced ... Financing. Capital raised will fund US and European approval ... Terms of the financing were not disclosed. ... Pharmaceuticals is a patient- and physician-founded company devoted to ...
... a leader in Quality of Daily Life Solutions announced ... the agreement, Sodexo will offer technology-enabled solutions by Healthsense ... Sodexo,s current offerings to realize their vision of improved ... communities they serve.   Healthsense is an ...
Cached Medicine Technology:Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 2Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 3
(Date:7/29/2014)... Summer is here, and that means it’s time to soak up ... pool or laying out on the beach. However, warm weather can ... is here to help pet owners protect their dogs from these ... completely keep fleas and ticks at bay, but there are steps ... coming into contact with fleas and ticks. , Flea eggs can ...
(Date:7/29/2014)... Bret Busacker , a partner in ... been appointed to the Board of Directors for the ... an experienced business attorney with a focus on employee ... a wide spectrum of topics regarding equity and incentive ... concerns. His clients include public and private businesses, governmental ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market ... Glycol Fluids, & Others), by Application (Oil & Gas, ... - Trends & Forecasts to 2019” defines and segments ... and forecast of the global consumption in terms of ... 64 figures spread through 199 page sand in-depth TOC ...
(Date:7/29/2014)... News) -- Quitting smoking is harder for people with ... make it more difficult to ride out the anxiety, cravings ... cold turkey, scientists found. But extra exercise -- even just ... "The review should be seen as a call to ... the department of exercise science at Concordia University in Montreal, ...
(Date:7/29/2014)... 29, 2014 More Zeppelin than Zen, the ... will soon be having a complete renovation and, upon its ... rock one’s body and soul. , The Rock Spa® will ... in job opportunities for experienced hair and nail stylists. Both ... time team members will be given full medical and health ...
Breaking Medicine News(10 mins):Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Rock Spa® at Seminole Hard Rock Hotel & Casino Tampa Prepares for Expansion 2
... after having their tonsils and adenoids removed to treat ... over time they may relapse or even worsen. African-American ... from Cincinnati Childrens Hospital Medical Center. , Adenotonsillectomy ... from about 19 per 10,000 in Canada to 115 ...
... 14 Murad, where skincare,meets healthcare(R), today ... the,company,s new Vice President of Global Marketing ... pivotal lead in driving brand growth and ... market,opportunities, driving product development, increasing brand profitability,and ...
... Policy Changes in Handling Credit ... ... today that he has reached a settlement with TransUnion over his,lawsuit against ... TransUnion is the first of six credit reporting companies and banks,which ...
... - Body Mass Index (BMI), the measure of a person,s ... effective prognostic tool for specific types of breast cancer, according ... Cancer Center. , The study, published in the March 15 ... breast cancer (LABC) and inflammatory breast cancer (IBC) with high ...
... PHILADELPHIA Women with breast cancer have more aggressive ... or obese, according to findings published in the March ... the American Association for Cancer Research. , The ... disease, said Massimo Cristofanilli, MD, associate professor of medicine ...
... MNKD ), focused on discovering, developing and,commercializing treatments ... at the Cowen and Company Healthcare Conference on March ... Place Hotel in Boston, MA., Interested parties can ... the,presentation in the Investor Relations section of the Company,s ...
Cached Medicine News:Health News:The ABCs of childhood z's: Snoring may be chronic despite surgery 2Health News:Murad, Inc., Hires Lori Jacobus as Vice President of Global Marketing 2Health News:Leukemia Survivor Reaches Landmark Settlement With TransUnion in ID Theft Case 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 3Health News:Breast cancer more aggressive among obese women 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: